KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Amgen (AMGN) Long-Term Debt Issuances (2016 - 2023)

Historic Long-Term Debt Issuances for Amgen (AMGN) over the last 12 years, with Q4 2023 value amounting to $4.0 billion.

  • Amgen's Long-Term Debt Issuances rose 2113157.89% to $4.0 billion in Q4 2023 from the same period last year, while for Sep 2024 it was $4.0 billion, marking a year-over-year decrease of 8318.32%. This contributed to the annual value of $27.8 billion for FY2023, which is 30145.97% up from last year.
  • Per Amgen's latest filing, its Long-Term Debt Issuances stood at $4.0 billion for Q4 2023, which was up 2113157.89% from $1.0 million recorded in Q3 2023.
  • Over the past 5 years, Amgen's Long-Term Debt Issuances peaked at $23.8 billion during Q1 2023, and registered a low of -$88.0 million during Q3 2020.
  • Moreover, its 4-year median value for Long-Term Debt Issuances was $3.0 billion (2022), whereas its average is $3.7 billion.
  • As far as peak fluctuations go, Amgen's Long-Term Debt Issuances tumbled by 180000.0% in 2022, and later soared by 2113157.89% in 2023.
  • Over the past 4 years, Amgen's Long-Term Debt Issuances (Quarter) stood at -$88.0 million in 2020, then surged by 98.86% to -$1.0 million in 2021, then plummeted by 1800.0% to -$19.0 million in 2022, then soared by 21131.58% to $4.0 billion in 2023.
  • Its last three reported values are $4.0 billion in Q4 2023, $1.0 million for Q3 2023, and -$18.0 million during Q2 2023.